What Is Remicade (Infliximab)?
Remicade (infliximab) is a biologic medication that suppresses inflammation. It was originally approved by the FDA in 1998 to treat patients with Crohn’s disease. Since then, its uses have expanded, and it is now prescribed to children and adults for a variety of autoimmune diseases, including ulcerative colitis, rheumatoid arthritis, plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis. Remicade is typically prescribed when other medications or types of treatments have not been effective in reducing symptoms. (Source, Source)
While it can be effective in treating these conditions and is generally considered safe, Remicade can also cause side effects, some of which can last for several weeks or months. The duration of side effects varies among individuals depending on several factors, including overall health, other medications, and specific reaction type. In this article we’ll look at how long Remicade side effects last and how they might be mitigated or reduced.
How Does Remicade Work?
Remicade is a type of immunotherapy that works by blocking the action of tumor necrosis factor alpha (TNF-α), a pro-inflammatory cytokine, or signaling protein, that is often released in excess in people with inflammatory autoimmune conditions. By doing this, it helps to reduce inflammation and relieve associated symptoms. (Source, Source)
Remicade Infusion Schedule
Remicade is administered via intravenous infusion, usually through a vein in the arm. Treatment typically starts with infusions at 0, 2, and 6 weeks. After these initial infusions, maintenance treatment is typically every 8 weeks, but may be every 4 or 6 weeks depending on the individual and specific autoimmune condition. Each infusion usually takes about 2 hours. (Source)
What Are the Side Effects of Remicade?
Remicade is often associated with side effects, which can range from mild and common to severe and rare. For some patients, side effects may present immediately following the injection, while others may experience them later. Remicade also carries a "black box warning" indicating severe health risks, including potentially fatal fungal infections, liver damage, and certain cancers. (Source, Source)
Common Remicade Side Effects
Common side effects during and after infusion may include fever, dizziness, itching or rash, and shortness of breath. In general, these infusion reactions occur within 24 hours. Other side effects include muscle and joint pain, fever, fatigue, and rash, which can occur up to 14 days after the infusion. (Source, Source)
Serious Remicade Side Effects
In some cases, more serious side effects may occur that can last longer and require further medical intervention. Most severe side effects are noted under the FDA's “black box” warning and can include:
- allergic reactions
- breathing difficulties, such as shortness of breath
- vision changes
- seizures
- infection, including fungal infection
- liver damage or failure
- stroke symptoms
- heart failure
- decreased white blood cell count
- unexplained bleeding or bruising
(Source, Source, Source, Source)
Persistent or severe side effects should always be reported to a health care provider. They can provide advice on managing these symptoms, or may decide to adjust the dosage or switch to a different medication.
Remicade Risks and Contraindications
There are also certain risks and contraindications associated with Remicade.
Remicade and Pregnancy
If taken during the third trimester of pregnancy, infliximab can cross the placenta and stay in a baby's body for up to 6 months after birth. This may potentially lead to neutropenia (lower levels of neutrophils, a type of white blood cells) in the baby. However, while there is evidence to suggest a correlation between Remicade administered during the third trimester and neutropenia in the infant, there is no definitive research that shows infliximab causes neutropenia. It is generally recommended to stop Remicade treatment during the third trimester of pregnancy as a precaution. (Source, Source, Source)
Remicade and Live Vaccines
There are also precautions against receiving live vaccines, which are made from microbes that are weakened but still alive, while being treated with Remicade. Since infliximab is an immunosuppressant, live vaccines carry a risk of causing infection. It is recommended that infants exposed to infliximab in the uterus not receive live vaccines for 6 months after birth, or until there is no infliximab detectable in their blood. Similarly, adults are advised to obtain any needed live vaccines before starting treatment with infliximab. Remicade should also not be used in patients with conditions such as heart failure or active infections. (Source, Source)
Remicade and Allergic Reactions
As severe side effects are often related to allergic reactions or serious systemic responses, their duration can vary widely based on the individual’s overall health and the specific adverse reaction in question. For example, acute allergic reactions can occur rapidly but resolve quickly with appropriate treatment, while systemic effects such as infection or liver failure can persist over a long time period and require more complex treatment.
How Long Do Remicade Side Effects Last?
The duration of Remicade side effects can vary greatly depending on several factors, including the individual's overall health, the presence of any other medical conditions, the dosage of the medication, and how well the individual's body metabolizes the drug. Some side effects can begin during or shortly after the infusion, while others might not appear until days or weeks later.
Generally speaking, mild side effects are likely to last for a few hours to a few days, and diminish over time as the body acclimatizes to the medication. Many common, less severe side effects will improve on their own and should resolve within a few days or weeks of starting treatment. More severe side effects may last longer, sometimes up to several weeks or months, and can become more severe over time.
Infusion Reactions
When receiving Remicade treatment, infusion reactions may be immediate or late, depending on the timing and characteristics of the side effects that can occur in response to Remicade. Both types of reactions can vary greatly in severity and should be monitored carefully. (Source)